IBEX Reports Record Q4 Revenue Growth, Strong Health Tech Performance, and Expanding AI Deployments
IBEX Limited reported record fourth-quarter revenue of $164.3 million, a 12% year-over-year increase, with full fiscal 2026 revenue reaching $644.1 million, up 15.4%. The company's health tech segment saw particularly strong growth, rising 42% in Q4 to $29.4 million and growing 38% for the full year to $114 million. The firm is also gaining traction with AI agent deployments across five verticals, including partnerships with Philippine Airlines and BJ's Wholesale. Management emphasized that these AI tools are intended to complement human services rather than replace them. IBEX expects fiscal 2027 revenue between $700 million and $715 million, representing growth of 9% to 11%, along with adjusted EBITDA in the range of $90 million to $94 million. The company added nine new clients during Q4, bringing its annual total to 17. It also repurchased $14.4 million worth of stock and ended fiscal 2026 with $30.9 million in net cash.
Tickers: $IBEX
Topics: AI_deployment health_tech revenue_growth stock_repurchase